Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enarodustat tablets at different starting doses for anemia in non-dialysis chronic kidney disease
CTR20252865Phase 4Active
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of enarodustat in anemia of renal disease, sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd.. Started Sep 2025; status: active.
02
Drugs
enarodustat
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on CTR20252865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252865.